Prachi Sanghavi1, Anupam B Jena2, Joseph P Newhouse3, Alan M Zaslavsky4. 1. Interfaculty Initiative in Health Policy, Harvard University, Cambridge, Massachusetts. 2. Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts3Massachusetts General Hospital, Boston4National Bureau of Economic Research, Cambridge, Massachusetts. 3. Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts4National Bureau of Economic Research, Cambridge, Massachusetts5Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts6Harvard Kenne. 4. Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
Abstract
IMPORTANCE: Most out-of-hospital cardiac arrests receiving emergency medical services in the United States are treated by ambulance service providers trained in advanced life support (ALS), but supporting evidence for the use of ALS over basic life support (BLS) is limited. OBJECTIVE: To compare the effects of BLS and ALS on outcomes after out-of-hospital cardiac arrest. DESIGN, SETTING, AND PARTICIPANTS: Observational cohort study of a nationally representative sample of traditional Medicare beneficiaries from nonrural counties who experienced out-of-hospital cardiac arrest between January 1, 2009, and October 2, 2011, and for whom ALS or BLS ambulance services were billed to Medicare (31,292 ALS cases and 1643 BLS cases). Propensity score methods were used to compare the effects of ALS and BLS on patient survival, neurological performance, and medical spending after cardiac arrest. MAIN OUTCOMES AND MEASURES: Survival to hospital discharge, to 30 days, and to 90 days; neurological performance; and incremental medical spending per additional survivor to 1 year. RESULTS: Survival to hospital discharge was greater among patients receiving BLS (13.1% vs 9.2% for ALS; 4.0 [95% CI, 2.3-5.7] percentage point difference), as was survival to 90 days (8.0% vs 5.4% for ALS; 2.6 [95% CI, 1.2-4.0] percentage point difference). Basic life support was associated with better neurological functioning among hospitalized patients (21.8% vs 44.8% with poor neurological functioning for ALS; 23.0 [95% CI, 18.6-27.4] percentage point difference). Incremental medical spending per additional survivor to 1 year for BLS relative to ALS was $154,333. CONCLUSIONS AND RELEVANCE: Patients with out-of-hospital cardiac arrest who received BLS had higher survival at hospital discharge and at 90 days compared with those who received ALS and were less likely to experience poor neurological functioning.
IMPORTANCE: Most out-of-hospital cardiac arrests receiving emergency medical services in the United States are treated by ambulance service providers trained in advanced life support (ALS), but supporting evidence for the use of ALS over basic life support (BLS) is limited. OBJECTIVE: To compare the effects of BLS and ALS on outcomes after out-of-hospital cardiac arrest. DESIGN, SETTING, AND PARTICIPANTS: Observational cohort study of a nationally representative sample of traditional Medicare beneficiaries from nonrural counties who experienced out-of-hospital cardiac arrest between January 1, 2009, and October 2, 2011, and for whom ALS or BLS ambulance services were billed to Medicare (31,292 ALS cases and 1643 BLS cases). Propensity score methods were used to compare the effects of ALS and BLS on patient survival, neurological performance, and medical spending after cardiac arrest. MAIN OUTCOMES AND MEASURES: Survival to hospital discharge, to 30 days, and to 90 days; neurological performance; and incremental medical spending per additional survivor to 1 year. RESULTS: Survival to hospital discharge was greater among patients receiving BLS (13.1% vs 9.2% for ALS; 4.0 [95% CI, 2.3-5.7] percentage point difference), as was survival to 90 days (8.0% vs 5.4% for ALS; 2.6 [95% CI, 1.2-4.0] percentage point difference). Basic life support was associated with better neurological functioning among hospitalized patients (21.8% vs 44.8% with poor neurological functioning for ALS; 23.0 [95% CI, 18.6-27.4] percentage point difference). Incremental medical spending per additional survivor to 1 year for BLS relative to ALS was $154,333. CONCLUSIONS AND RELEVANCE: Patients with out-of-hospital cardiac arrest who received BLS had higher survival at hospital discharge and at 90 days compared with those who received ALS and were less likely to experience poor neurological functioning.
Authors: Ian G Stiell; George A Wells; Brian Field; Daniel W Spaite; Lisa P Nesbitt; Valerie J De Maio; Graham Nichol; Donna Cousineau; Josée Blackburn; Doug Munkley; Lorraine Luinstra-Toohey; Tony Campeau; Eugene Dagnone; Marion Lyver Journal: N Engl J Med Date: 2004-08-12 Impact factor: 91.245
Authors: A Bur; H Kittler; F Sterz; M Holzer; P Eisenburger; E Oschatz; J Kofler; A N Laggner Journal: Intensive Care Med Date: 2001-09 Impact factor: 17.440
Authors: Jerry P Nolan; Francisco J De Latorre; Petter A Steen; Douglas A Chamberlain; Leo L Bossaert Journal: Curr Opin Crit Care Date: 2002-06 Impact factor: 3.687
Authors: Stephen A Bernard; Timothy W Gray; Michael D Buist; Bruce M Jones; William Silvester; Geoff Gutteridge; Karen Smith Journal: N Engl J Med Date: 2002-02-21 Impact factor: 91.245
Authors: Rebekah W Moehring; Russell Staheli; Becky A Miller; Luke Francis Chen; Daniel John Sexton; Deverick John Anderson Journal: Infect Control Hosp Epidemiol Date: 2013-01-18 Impact factor: 3.254
Authors: Comilla Sasson; David J Magid; Paul Chan; Elisabeth D Root; Bryan F McNally; Arthur L Kellermann; Jason S Haukoos Journal: N Engl J Med Date: 2012-10-25 Impact factor: 91.245
Authors: A P Hallstrom; J P Ornato; M Weisfeldt; A Travers; J Christenson; M A McBurnie; R Zalenski; L B Becker; E B Schron; M Proschan Journal: N Engl J Med Date: 2004-08-12 Impact factor: 91.245
Authors: Amresh D Hanchate; Michael K Paasche-Orlow; K Sophia Dyer; William E Baker; Chen Feng; James Feldman Journal: Ann Emerg Med Date: 2017-05-27 Impact factor: 5.721
Authors: Simon A Amacher; Chantal Bohren; René Blatter; Christoph Becker; Katharina Beck; Jonas Mueller; Nina Loretz; Sebastian Gross; Kai Tisljar; Raoul Sutter; Christian Appenzeller-Herzog; Stephan Marsch; Sabina Hunziker Journal: JAMA Cardiol Date: 2022-06-01 Impact factor: 30.154
Authors: Jonathan Elmer; Cesar Torres; Tom P Aufderheide; Michael A Austin; Clifton W Callaway; Eyal Golan; Heather Herren; Jamie Jasti; Peter J Kudenchuk; Damon C Scales; Dion Stub; Derek K Richardson; Dana M Zive Journal: Resuscitation Date: 2016-02-03 Impact factor: 5.262
Authors: Patrick Zuercher; Dirk Springe; Denis Grandgirard; Stephen L Leib; Marius Grossholz; Stephan Jakob; Jukka Takala; Matthias Haenggi Journal: BMC Neurol Date: 2016-04-04 Impact factor: 2.474